
-
Iran missiles kill 10 in Israel in night of mutual attacks
-
'This is a culture': TikTok murder highlights Pakistan's unease with women online
-
Families hold funerals for Air India crash victims
-
US Fed set to hold rates steady in the face of Trump pressure
-
Sober clubbing brews fresh beat for Singapore Gen Z
-
Cummins flags Australia shake-up after WTC defeat as Ashes loom
-
Mexico down Dominican Republic to open Gold Cup defence
-
Pochettino defends Pulisic omission: 'I'm not a mannequin'
-
Panthers on brink of Stanley Cup repeat after 5-2 win over Oilers
-
Messi denied late winner in Club World Cup opener
-
Trump flexes military might at parade as protests sweep US
-
New-look Man City crave winning feeling at Club World Cup
-
Big tech on a quest for ideal AI device
-
Guest list for G7 summit tells of global challenges
-
Macron to Greenland in show of support after Trump threats
-
'Mass grave' excavation to finally start at Irish mother and baby home
-
'Hidden treasure': Rare Gandhi portrait up for UK sale
-
Fearless Chiefs plot raid on Crusaders fortress in Super Rugby final
-
US Open leader Burns eyes first major title at historic Oakmont
-
Messi gets Club World Cup under way in Miami
-
Burns grabs US Open lead with Scott and Spaun one back
-
Russell grabs dazzling Canadian GP pole then jokes at Verstappen's expense
-
Thompson in six-way tie for LPGA lead in Michigan
-
Inter striker Taremi stranded in Iran amid conflict: club
-
No.1 Scheffler well back as pal Burns fights for US Open title
-
Trump's military parade kicks off as protests sweep US
-
PSG excitement for Club World Cup trumps fatigue ahead of Atletico clash
-
Burns and Spaun share US Open lead through nine holes of third round
-
Toulon power past Castres and into Top 14 semi-final
-
Russell delivers sensational lap to take pole at Canadian GP
-
Anti-Trump protesters rally across US ahead of military parade
-
Iran activates air defences, Israelis told to shelter as both sides trade strikes
-
McIlroy opens up on silence after golf and post-Masters funk
-
US Steel, Nippon partnership proceeds with security deal, 'golden share'
-
Burns tees off with US Open lead as McIlroy finds more misery
-
Three things we learned from the World Test Championship final
-
Putin tells Trump Russia is ready for next round of Ukraine talks
-
Israel, Iran trade threats as conflict escalates
-
US protesters hit streets before Trump's military parade
-
'We are strong': Israelis defiant despite deadly Iran strikes
-
Bavuma eyes more South Africa success after Test final win over Australia
-
Former Nicaragua president Violeta Chamorro dead at 95
-
France says supports Harvard, welcomes foreign students
-
Minnesota lawmaker shot dead, another wounded in targeted attack
-
Federer gets 93rd Le Mans underway as Ferrari chase third successive win
-
Nicklaus and Miller's US Open advice -- patience and attitude
-
Pogacar again soars away from stellar field to increase Criterium du Dauphine lead
-
MMA draws thousands in Nigeria as fight sport gains ground
-
Cummins says WTC final 'a bridge too far' for beaten Australia
-
Trump set for huge US military parade amid 'No Kings' protests

US greenlights pig kidney transplant trials
Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.
United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.
Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.
United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.
The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.
The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.
Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.
"The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe," the company said.
Xenotransplantation -- transplanting organs from one species to another -- has been a tantalizing yet elusive goal for science.
Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.
Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.
United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections -- diseases that jump from animals to humans.
Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.
She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.
K.Sutter--VB